| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $112K | -74.9% |
| SG&A Expense | $100K | -38.8% |
| Net Income | -$415K | +78.2% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Current Assets | $21K | -19.3% |
| Total Assets | $481K | +3.8% |
| Current Liabilities | $45K | +7.6% |
| Stockholders' Equity | $436K | +3.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$376K | +53.3% |
| Investing Cash Flow | -$59K | +55.2% |
| Financing Cash Flow | $430K | -52.5% |